权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Identifying Host and Pathogen Factors That Control Growth in Microsporidia

识别控制微孢子虫生长的宿主和病原体因素

基本信息

批准号：
9042831
负责人：
Michael R. Botts
金额：
$ 5.8万
依托单位：
UNIVERSITY OF WISCONSIN-MADISON
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-02-01 至 2018-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9042831
关键词：
Affect Albendazole Animal Model Animals Binding Binding Sites Caenorhabditis elegans Cells Complex Crohn&apos s disease DNA Binding Development Diarrhea Disease Enterocytozoon bieneusi Fungal Spores Genes Genome Goals Growth Health Human Immune Immunocompromised Host Infection Integration Host Factors Intestines Invaded Invertebrates Life Style Light Mediating Mentors Microsporidia Microsporidiosis Modeling Molecular Nematoda Organism Pathogenesis Pathway interactions Pharmaceutical Preparations Population Positioning Attribute Process Production Proliferating Proteins Reproduction spores Research Resources Signal Pathway Signal Transduction Staging Structure System Therapeutic Therapeutic Intervention Time TimeLine Tissues cell type combat fungus genetic approach insight latent infection novel novel strategies novel therapeutics pathogen public health relevance tool transcription factor wasting

项目摘要

DESCRIPTION (provided by applicant): Microsporidia comprise a phylum of fungal-like obligate intracellular pathogens that infect hosts ranging from invertebrates to humans. In immunocompromised humans, microsporidia can cause fatal wasting diarrhea. Latent infection by microsporidia is a common phenomenon, with up to 56% of the immune- competent population asymptomatically infected and transiently shedding spores. The full impact of these pathogens on human health is unknown. There is a critical lack of effective drugs to treat microsporidiosis. Only one drug is approved for treating humans, albendazole, which is ineffective against the leading cause of microsporidiosis, Enterocytozoon bieneusi. Determining the molecular mechanisms of microsporidian pathogenesis is critical for understanding how these pathogens cause disease and for developing new strategies for therapeutic intervention. Adaptation of microsporidia to this intracellular parasitic lifestyle has resulted in extreme gene loss and genome compaction, including the loss of conserved signaling components responsible for controlling proliferation and sporulation in other fungi. In addition, this obligat intracellular lifestyle of microsporidia has severely hampered the ability to propagate and study these organisms and is the primary reason for such a poor understanding of these pathogens. However, the discovery of Nematocida parisii, a natural pathogen of the model nematode Caenorhabditis elegans, provides a tractable system for understanding the molecular mechanisms of microsporidian pathogenesis in a whole animal model. I hypothesize that both microsporidian and host cell signaling pathways regulate microsporidia proliferation and differentiation into spores. I will take advantage of the N. parisii/C. elegans infection system to identify the host signals that control microsporidian proliferation and spore production. Then, I will analyze candidate developmental regulators of N. parisii sporulation to determine their stage-specific expression, and characterize the direct targets of these transcription factors. Ultimately, these studies will shed light on host factors critical for microsporidian pathogenesis, and developmentally regulated genes in microsporidia; genes important for the formation of infectious spores. Genes expressed during microsporidian differentiation are likely to include many genes responsible for coordinating egress from host cells, forming specialized spore- structures, including those responsible for invading host cells. Host genes that are required for microsporidian proliferation and differentiation into spores are key targets for novel strategies t combat these ubiquitous pathogens.